跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG
Approved
THERAPEUTIC
PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG
Gland Pharma Limited
🇸🇬 Health Sciences Authority
Approval Date
Mar 11, 2020
Approval ID
0b94d5140357f730
Company
Gland Pharma Limited
Type
Therapeutic
Approval Details
Approval Id
0b94d5140357f730
Drug Name
PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG
Product Name
PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG
Approval Number
SIN15900P
Approval Date
2020-03-11
Registrant
PFIZER PRIVATE LIMITED
Licence Holder
PFIZER PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS, SUBCUTANEOUS
Atc Code
L01XX32
Atc Item Name
xl 01 xx 32
Pharma Manufacturer Name
PFIZER PRIVATE LIMITED
Company Detail Path
/organization/pfizer-private-limited
Active Ingredients
Bortezomib (as a mannitol boronic ester)
3.50mg
Bortezomib (as a mannitol boronic ester)
3.50mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 11, 2020
Approval ID
0b94d5140357f730
Type
Therapeutic
Back to HSA Approvals
PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG - HSA Drug Approval Details
